EUVIMEDEUVIMED entdecken
Crossref

Tumor-Infiltrating Lymphocyte Therapy Receives FDA Approval

Jennifer Strong, David Miller, Brownell Isaac

Journal of Cutaneous Oncology · 2024

DOI: 10.59449/joco.2024.05.01 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Cutaneous Oncology, 2024. Verfasst von Jennifer Strong und 2 weiteren Autor:innen. Die Arbeit nennt 16 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Strong, J., Miller, D., & Isaac, B. (2024). Tumor-Infiltrating Lymphocyte Therapy Receives FDA Approval. Journal of Cutaneous Oncology. https://doi.org/10.59449/joco.2024.05.01

Vancouver

Strong J, Miller D, Isaac B. Tumor-Infiltrating Lymphocyte Therapy Receives FDA Approval. Journal of Cutaneous Oncology. 2024. doi:10.59449/joco.2024.05.01

BibTeX
@article{Strong2024,
  author = {Strong, Jennifer and Miller, David and Isaac, Brownell},
  title = {Tumor-Infiltrating Lymphocyte Therapy Receives FDA Approval},
  journal = {Journal of Cutaneous Oncology},
  year = {2024},
  doi = {10.59449/joco.2024.05.01}
}
Kostenlos starten →